Complete Filing Data
zSpace, Inc. reported Stockholders Equity of -$22.51 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean zSpace, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income * | -$25.4M | -$20.8M |
| Selling And Marketing Expense | $16.2M | $15.9M |
| Revenue From Contract With Customer Excluding Assessed Tax | $27.9M | $38.1M |
| Research And Development Expense | $5.3M | $4.9M |
| Other Nonoperating Income Expense | $190.0K | $43.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$186.0K | $101.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$186.0K | $101.0K |
| Operating Income Loss | -$22.1M | -$17.7M |
| Operating Expenses | $35.4M | $33.2M |
| Net Income Loss Available To Common Stockholders Diluted | -$25.4M | $23.7M |
| Net Income Loss Available To Common Stockholders Basic | -$25.4M | $22.5M |
| Interest Expense Nonoperating | $1.5M | $2.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$25.4M | -$20.8M |
| Gross Profit | $13.3M | $15.6M |
| General And Administrative Expense | $13.9M | $12.4M |
| Cost Of Revenue | $14.6M | $22.5M |
| Comprehensive Income Net Of Tax | -$25.6M | -$20.7M |
| Income Tax Expense Benefit | $14.0K | $34.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | -$6.2M | -$6.1M | -$5.8M | -$204.0K | -$4.7M | -$12.2M |
| Selling And Marketing Expense | $4.3M | $3.9M | $4.0M | $3.3M | $3.4M | $5.5M |
| Revenue From Contract With Customer Excluding Assessed Tax | $8.8M | $7.5M | $6.8M | $14.2M | $7.5M | $7.8M |
| Research And Development Expense | $1.6M | $1.3M | $1.1M | $1.0M | $1.1M | $2.0M |
| Other Nonoperating Income Expense | $78.0K | $14.0K | $56.0K | $368.0K | -$268.0K | -$82.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$14.0K | -$59.0K | -$72.0K | -$146.0K | $37.0K | $74.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$14.0K | -$59.0K | -$72.0K | -$146.0K | $37.0K | $74.0K |
| Operating Income Loss | -$4.8M | -$6.3M | -$5.4M | $24.0K | -$3.5M | -$11.4M |
| Operating Expenses | $9.3M | $9.5M | $8.6M | $6.3M | $6.6M | $14.1M |
| Net Income Loss Available To Common Stockholders Diluted | -$6.2M | -$6.1M | -$5.8M | $43.5M | -$4.8M | -$12.3M |
| Net Income Loss Available To Common Stockholders Basic | -$6.2M | -$6.1M | -$5.8M | $43.4M | -$4.8M | -$12.3M |
| Interest Expense Nonoperating | $306.0K | $301.0K | $502.0K | $596.0K | $910.0K | $729.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.2M | -$6.1M | -$5.8M | -$204.0K | -$4.7M | -$12.3M |
| Gross Profit | $4.5M | $3.2M | $3.2M | $6.4M | $3.0M | $2.7M |
| General And Administrative Expense | $3.4M | $4.3M | $3.5M | $2.0M | $2.1M | $6.6M |
| Cost Of Revenue | $4.3M | $4.3M | $3.6M | $7.9M | $4.5M | $5.1M |
| Comprehensive Income Net Of Tax | -$6.2M | -$6.2M | -$5.9M | -$350.0K | -$4.7M | -$12.2M |
| Income Tax Expense Benefit | -$1.0K | $11.0K | $2.0K | $39.0K | -$5.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | -$22.5M | -$14.7M | -$130.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0M | $4.9M | $3.1M |
| Repayments Of Other Long Term Debt | $7.2M | $5.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.8M | $1.7M | |
| Amortization Of Debt Discount Premium | $66.0K | $59.0K | |
| Retained Earnings Accumulated Deficit | -$315.8M | -$290.4M | |
| Property Plant And Equipment Net | $37.0K | $21.0K | |
| Prepaid Expense And Other Assets Current | $1.6M | $1.7M | |
| Liabilities Current | $17.3M | $20.9M | |
| Liabilities And Stockholders Equity | $7.6M | $13.5M | |
| Liabilities | $30.1M | $28.2M | |
| Inventory Net | $2.4M | $3.2M | |
| Interest Payable Noncurrent | $2.4M | $819.0K | |
| Contract With Customer Liability Noncurrent | $320.0K | $318.0K | |
| Contract With Customer Liability Current | $1.9M | $3.3M | |
| Assets Current | $6.5M | $12.9M | |
| Assets | $7.6M | $13.5M | |
| Allowance For Doubtful Accounts Receivable Current | $94.0K | $44.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $143.0K | $329.0K | |
| Accrued Liabilities And Other Liabilities Excluding Accrued Interest Current | $3.7M | $5.4M | |
| Accounts Receivable Net Current | $1.4M | $3.2M | |
| Accounts Payable Current | $4.1M | $5.7M | |
| Interest Payable Current | $12.0K | $783.0K | |
| Long Term Debt Excluding Convertible Debt Noncurrent | $7.4M | $6.2M | |
| Inventory Write Down | $227.0K | $402.0K | |
| Debt Conversion Converted Instrument Amount1 | $4.9M | ||
| Temporary Equity Issued In Exchange For Related Party Debt And Accrued Interest | $5.2M | ||
| Long Term Debt Excluding Convertible Debt Current | $1.4M | $5.8M | |
| Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost | -$359.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$19.7M | -$22.3M | -$19.6M | -$96.6M | -$140.0M | -$135.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.3M | $1.4M | $1.1M | $3.2M | $3.0M | $1.2M |
| Repayments Of Other Long Term Debt | $992.0K | $1.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.7M | -$1.9M | ||||
| Amortization Of Debt Discount Premium | $17.0K | $18.0K | ||||
| Retained Earnings Accumulated Deficit | -$308.5M | -$302.3M | -$296.2M | |||
| Property Plant And Equipment Net | $35.0K | $33.0K | $19.0K | |||
| Prepaid Expense And Other Assets Current | $3.1M | $3.4M | $2.8M | |||
| Liabilities Current | $19.6M | $20.7M | $19.9M | |||
| Liabilities And Stockholders Equity | $13.5M | $12.1M | $9.8M | |||
| Liabilities | $33.1M | $34.4M | $29.5M | |||
| Inventory Net | $2.3M | $2.6M | $2.0M | |||
| Interest Payable Noncurrent | $2.2M | $2.0M | $1.6M | |||
| Contract With Customer Liability Noncurrent | $320.0K | $305.0K | $287.0K | |||
| Contract With Customer Liability Current | $2.7M | $3.4M | $2.9M | |||
| Assets Current | $13.3M | $12.0M | $9.8M | |||
| Assets | $13.5M | $12.1M | $9.8M | |||
| Allowance For Doubtful Accounts Receivable Current | $34.0K | $34.0K | $46.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $184.0K | $198.0K | $257.0K | |||
| Accrued Liabilities And Other Liabilities Excluding Accrued Interest Current | $5.3M | $5.3M | $5.5M | |||
| Accounts Receivable Net Current | $3.6M | $4.6M | $3.8M | |||
| Accounts Payable Current | $4.0M | $5.2M | $6.0M | |||
| Interest Payable Current | $14.0K | $229.0K | ||||
| Long Term Debt Excluding Convertible Debt Noncurrent | $7.7M | $7.2M | ||||
| Inventory Write Down | $6.0K | |||||
| Debt Conversion Converted Instrument Amount1 | $2.4M | $1.5M | ||||
| Temporary Equity Issued In Exchange For Related Party Debt And Accrued Interest | $5.2M | |||||
| Long Term Debt Excluding Convertible Debt Current | $1.4M | |||||
| Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost | -$52.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Share Based Compensation | $7.1M | $7.7M |
| Net Cash Provided By Used In Operating Activities | -$18.0M | -$8.9M |
| Net Cash Provided By Used In Financing Activities | $14.4M | $10.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $498.0K | $256.0K |
| Increase Decrease In Inventories | -$652.0K | $105.0K |
| Increase Decrease In Interest Payable Net | $764.0K | $1.6M |
| Increase Decrease In Contract With Customer Liability | -$1.4M | $601.0K |
| Increase Decrease In Accrued Liabilities | -$1.6M | -$1.1M |
| Increase Decrease In Accounts Receivable | -$1.6M | -$1.9M |
| Increase Decrease In Accounts Payable | -$1.6M | $921.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$230.0K | $141.0K |
| Proceeds From Convertible Debt | $13.0M | $5.0M |
| Payments For Proceeds From Productive Assets | $26.0K | $13.0K |
| Net Cash Provided By Used In Investing Activities | -$26.0K | -$13.0K |
| Proceeds From Stock Options Exercised | $157.0K | $34.0K |
| Proceeds From Other Debt | $4.0M | $3.5M |
| Payments Of Debt Issuance Costs | $61.0K | $18.0K |
| Payments Of Deferred Offering Costs | $2.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Share Based Compensation | $973.0K | $7.3M |
| Net Cash Provided By Used In Operating Activities | -$4.6M | -$5.4M |
| Net Cash Provided By Used In Financing Activities | $978.0K | $3.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $647.0K | $233.0K |
| Increase Decrease In Inventories | -$1.2M | $508.0K |
| Increase Decrease In Interest Payable Net | $275.0K | $287.0K |
| Increase Decrease In Contract With Customer Liability | -$487.0K | $695.0K |
| Increase Decrease In Accrued Liabilities | $100.0K | $251.0K |
| Increase Decrease In Accounts Receivable | $662.0K | $1.4M |
| Increase Decrease In Accounts Payable | $367.0K | $457.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$72.0K | -$240.0K |
| Proceeds From Convertible Debt | $5.0M | |
| Payments For Proceeds From Productive Assets | ||
| Net Cash Provided By Used In Investing Activities | ||
| Proceeds From Stock Options Exercised | ||
| Proceeds From Other Debt | ||
| Payments Of Debt Issuance Costs | $30.0K | |
| Payments Of Deferred Offering Costs | $264.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 25.0M | 1.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 25.0M | 23.1M |
| Earnings Per Share Diluted | $-1.01 | $1.03 |
| Earnings Per Share Basic | $-1.01 | $13.03 |
| Common Stock Shares Outstanding | 32.4M | 22.8M |
| Common Stock Shares Issued | 32.4M | 22.8M |
| Common Stock Shares Authorized | 100.0M | 100.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Temporary Equity Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 24.0M | 23.0M | 22.8M | 183.9K | 174.1K | 174.1K | |
| Weighted Average Number Of Diluted Shares Outstanding | 24.0M | 23.0M | 22.8M | 6.3M | 174.1K | 174.1K | |
| Earnings Per Share Diluted | $-0.26 | $-0.27 | $-0.26 | $6.92 | $-27.73 | $-70.83 | |
| Earnings Per Share Basic | $-0.26 | $-0.27 | $-0.26 | $235.81 | $-27.73 | $-70.83 | |
| Common Stock Shares Outstanding | 26.5M | 23.2M | 22.8M | ||||
| Common Stock Shares Issued | 26.5M | 23.2M | 22.8M | ||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.7M | |
| Stock Issued During Period Value Stock Options Exercised | $156.0K | $34.0K |
| Interest Paid Net | $579.0K | $1.7M |
| Depreciation | $10.0K | $12.0K |
| Additional Paid In Capital | $293.1M | $275.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.4M | $1.9M | $973.0K | $51.0K | $97.0K | $7.3M |
| Stock Issued During Period Value Stock Options Exercised | $72.0K | $85.0K | $34.0K | |||
| Interest Paid Net | $210.0K | $424.0K | ||||
| Depreciation | $1.0K | $4.0K | ||||
| Additional Paid In Capital | $288.6M | $279.8M | $276.4M |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.